These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 5125072

  • 1. [Amantadine hydrochloride in patients with parkinsonism in a Geriatric Rehabilitation Center].
    Antonini FM, Baroni A.
    Minerva Med; 1971 Oct 31; 62(82):4027-30. PubMed ID: 5125072
    [No Abstract] [Full Text] [Related]

  • 2. Amantadine hydrochloride in treatment of Parkinsonism.
    Nagaswami S, Nagaswami R.
    Dis Nerv Syst; 1973 Oct 31; 34(5):253-8. PubMed ID: 4782280
    [No Abstract] [Full Text] [Related]

  • 3. [Long-term effects of amantadine in striatal syndromes].
    Rovetta P.
    Minerva Med; 1971 Oct 31; 62(82):3965-7. PubMed ID: 5125054
    [No Abstract] [Full Text] [Related]

  • 4. [Experience in the prolonged use of midantan (amantadine hydrochloride) in parkinsonism].
    Man'kovskii NB, Vainshtok AB, Oleinik LI.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973 Oct 31; 73(4):524-30. PubMed ID: 4705407
    [No Abstract] [Full Text] [Related]

  • 5. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation].
    Antonini F, Baroni A, Roveyaz L.
    Sist Nerv; 1970 Oct 31; 22(2):74-81. PubMed ID: 5504560
    [No Abstract] [Full Text] [Related]

  • 6. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
    Kiseleva AM, Zlydnikov DM, Mazhinskaia VP, Lebedeva VK, Zakharova NG.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973 Oct 31; 73(4):530-4. PubMed ID: 4705408
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [On the action of amantadine in postencephalitic parkinsonism].
    Pennacchietti M, Aletto PM.
    Minerva Med; 1971 Oct 31; 62(82):3960-2. PubMed ID: 5125052
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Results of treatment of Parkinsonism with L-dopa].
    De Divitiis E, D'Andrea F, Signorelli CD.
    Sist Nerv; 1970 Oct 31; 22(2):99-108. PubMed ID: 5504563
    [No Abstract] [Full Text] [Related]

  • 13. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
    Sigwald J, Raymondeaud C, Piot C.
    Rev Neurol (Paris); 1970 Feb 31; 122(2):145-8. PubMed ID: 4931718
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Trans-cerebral electrophoresis of L-DOPA in the complex treatment of parkinsonism].
    Neĭmark EZ, Evtushenko SK, Dukhovnaia MA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984 Feb 31; 84(9):1334-8. PubMed ID: 6506979
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment failures with L-dopa in Parkinsonism.
    Julsrud OJ.
    Acta Neurol Scand Suppl; 1972 Feb 31; 51():123-4. PubMed ID: 4514337
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.